- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Apr 23, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,630 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ATAKP | ₺46.08 | -2.2% | n/a | ₺6.4b | ₺67.66 | PE21.6x | E72.8% | n/a | Food, Beverage & Tobacco | ||
GWIND | ₺27.06 | 5.9% | 67.6% | ₺14.6b | ₺39.79 | PE23.4x | E60.9% | 1.7% | Utilities | ||
WAYS | kr22.20 | -5.5% | -57.7% | kr179.1m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
GIG | kr34.10 | -1.4% | 25.8% | kr4.4b | kr49.20 | PE28.1x | E39.8% | n/a | Consumer Services | ||
NVG | zł2.14 | -10.5% | 32.9% | zł74.9m | zł3.71 | PE7.7x | E28.5% | n/a | Diversified Financials | ||
MVW | kr8.10 | -4.7% | 3.8% | kr236.5m | kr12.20 | PS21.5x | E66.0% | n/a | Materials | ||
FDE | €34.60 | 8.1% | -3.4% | €181.0m | €64.07 | PE23x | E32.3% | n/a | Energy | ||
CALTX | kr100.40 | -0.1% | -22.2% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
RDUE | €9.60 | 1.1% | 2.8% | €60.0m | €10.50 | PE17.7x | E37.7% | n/a | Capital Goods | ||
OSE | €5.97 | 28.4% | 41.8% | €128.8m | €7.15 | PS57.8x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.72 | 3.2% | 101.0% | €133.7m | €12.75 | PE27.2x | E22.8% | n/a | Capital Goods | ||
KEBNI B | kr1.58 | 0.5% | 25.1% | kr427.3m | kr1.80 | PS5.9x | E96.2% | n/a | Tech | ||
NEWBRY | kr3.39 | -3.1% | -39.7% | kr82.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
NOHAL | kr22.60 | 0.9% | -5.8% | kr883.8m | kr32.50 | PS8.7x | E56.0% | n/a | Food, Beverage & Tobacco | ||
ELABS | kr16.20 | 16.5% | 36.1% | kr1.7b | kr25.00 | PS24.9x | E124.6% | n/a | Software | ||
ASND | US$144.83 | 1.9% | 89.5% | US$8.3b | US$177.45 | PS29x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.98 | -4.3% | -36.3% | US$231.7m | US$26.06 | PS4.6x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$73.08 | 4.8% | 4.2% | US$3.5b | US$121.13 | PS12.8x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
AVLL3 | R$3.55 | -8.0% | 28.2% | R$693.4m | R$9.90 | PS1.5x | E101.9% | n/a | Consumer Durables | ||
ELF | US$176.99 | 6.5% | 88.6% | US$9.8b | US$206.21 | PE75.9x | E27.2% | n/a | Household | ||
AESI | US$22.60 | 2.9% | 25.6% | US$2.5b | US$25.50 | PE23.5x | E43.0% | 3.7% | Energy | ||
ESTA | US$49.69 | -4.7% | -29.8% | US$1.4b | US$59.29 | PS8.3x | E65.4% | n/a | Healthcare | ||
ZVRA | US$4.58 | -1.3% | -11.6% | US$191.7m | US$19.00 | PS7x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$23.37 | 9.6% | 256.8% | CA$802.2m | CA$24.37 | PE21.1x | E33.6% | 2.0% | Diversified Financials |